Introduction
Hypoplastic left heart syndrome (HLHS) is a poorly understood single ventricle congenital heart defect (CHD) that accounts for 2-3% of all CHDs. [1] [2] [3] In HLHS, the LV is diminished in size and unable to support the systemic circulation. To account for the insufficiency, the RV is fed with oxygenated blood via an atrial septal defect directly connecting the right and left atriums or ventricular septal defects (VSD) directly connecting the RV and LV. Blood from the RV then exits the ventricle via the pulmonary artery and enters the aorta via a persistent ductus. Traditional linkage approaches have identified a growing number of mutations that give rise to survivable CHDs. [4] [5] [6] [7] [8] However, it has proved more difficult to identify CHD-causing genes as a result of early in utero lethality due to catastrophic failure of cardiogenesis, or alternatively, failure of other organ systems required for embryo viability. Such gene mutations cannot be inherited. It is suggested that the acquisition of somatic mutation(s) in such genes, which appear in only a subset of the cells in the developing embryo, could result in greater in utero viability or even in survivable CHDs; however, such a mechanism would likely be very rare. 9 HAND1, a bHLH transcription factor, is a prototypical example of a CHD-causing gene whose analysis has been hampered due to early embryonic lethality. [10] [11] [12] [13] The function of Hand1 is regulated by homo-or hetero-dimerization with other bHLH proteins through its bHLH domain. Hand1 forms dimers that bind E-box (CANNTG) and D-box (CGNNTG) cis-elements. [14] [15] [16] Deletion of Hand1 or hypomorphic Hand1 expression in mice results in cardiac morphogenic defects, and early embryonic lethality due to placental defects.
samples were unable to confirm these results. 22 Although it is clear that Hand1 plays an important role in cardiac morphogenesis, mutations within the HAND1 coding domains are unlikely to result in viable offspring; therefore, the idea that HAND1 mutations could occur somatically is an intriguing disease model. The controversy regarding somatic mutation as a disease model and the potential caveats of using fixed samples prompted us to address this question directly. We tested a reported Hand1 HLHS mutation (NP_004812.1 p.Ala126Profs13X) 21, 23 by generating a conditional activation knock-in allele (defined as Hand1
A126fs
) of this putative Hand1 somatic mutation.
Results show that in tissue culture analysis, the p.Ala126ProfsX13 mutant protein localizes to the nucleus and inhibits both DNA binding and transcriptional activation. Phenotypic and molecular analysis of Hand1 SFA126fs mice generated with Nkx2. we encounter less severe heart defects and mutant viability. We also employed the anterior heart field (AHF) Mef2cAHF-Cre driver 27 and
show similar OFT defects to Nkx2.5 Cre mutants; however, these mice also survive. Together, these data suggest that although the Hand1 p.Ala126Profs13X mutant protein has altered function, when expressed in mouse cardiomyocytes, it is not causative of HLHS.
Methods

Mouse strains, genotyping
SFHand1 A126FS was generated from ES cells targeted with the constructs described and genotyping by Southern blot 10 or with primers H1 5 0 -CTG CCA TTG GCT CCG GCT AGA GGT-3 0 and PGK 5 0 -GGC TGC TAA AGC GCA TGC TCC AGA CTG-3 0 using PCR conditions of 94 C 1 min, 60 C 1min, 72 C 1 min for 35 cycles. Nkx2.5 Cre 24 mice are a Crerecombinase knock-in allele that express Cre within the cardiac crescent at E7.5 marking myocardium, endocardium. 28 Hand1 is not expressed in edocardium. 25 aMHC-Cre transgenic mice express Cre recombinase at E9.5 within the myocardium after which the Cre is dormant until after birth.
26
Mef2CAHF-Cre is expressed endocardium and myocardium at E7. 5. 27 No anaesthetic/analgesic agents were used. Euthanasia was performed using CO 2 gas in a closed chamber followed by cervical dislocation. All experiments were performed conforming to the NIH guidelines following the Indiana University IACUC animal protocol 10809.
2.2
Cell transfection, luciferase assays, and electrophoretic mobility shift assays HEK293 CaPO 4 transfections and Luciferase assays protocol as described were performed as described. 29, 30 Ebox reporter, Dbox reporter, Hand1 pIRESNeo, and E12 pIRESNeo expression plasmids are described. 14, 31 Hand1A126fspIRESNeo was mutagenized using QuickChange Mutagenesis Kit (Agilent Technologies). Data represent six-independent experiments. Error bars denote SE. Asterisk represent significance of P < _ 0.05 by ANOVA.
2.2.1.Electrophoretic mobility shift assays
EMSAs were carried out as previously described.
14 EMSA probe Hand E-box (5 0 -gga ttc cat tgc atc tgg att cca gag-3 0 ) was used to shift and as specific competitor. Non-specific competitor oligo (5 0 -gga ttc cat tgGGtc AAg att cca gag-3 0 ).
Histology
Embryos (E9.5-E18.5) were processed as described. 13 Eight viable embryos per genotype were examined for all analyses. Bifurcated heart preparations were generated by cryo-sectioning.
In situ hybridization
Section and whole mount in situ hybridization (ISH) were performed as described 32, 33 for probes Hand1, Wnt11, Tbx5, Dkk3, Cited1, Bmp10, Nppa (Anf), Cxcl12, Tbx20, Hey2.
Lysotracker and EdU immunohistochemistry analysis
Lysotracker and Click-IT EdU Imaging (Life Technologies) was incubated with embryonic hearts as described. 26 ,32
Quantitative RTPCR (QPCR)
RNA Isolation and quantitative RT-PCR (QRTPCR) was performed as described. 32 Error bars denote the maximum and minimum relative level of gene expression set in the QuantStudio 3&5 software. Statistics employed Student's two-tailed t-test with P < _ 0.05 significance. N = 6.
Results
Hand1 A126FS acts as a dominant negative transcription factor
To confirm that the p.Ala126Profs13X protein (Hand1
A126FS
) functions as a dominant negative, we employed luciferase analysis, EMSA and cellular localization to test functionality ( Figure 1) . Hand1 A126FS truncates Hand1 within the NH4-terminal portion of the loop domain and is reported to not bind DNA and to repress transcriptional activation of both E-and D-box luciferase reporters in yeast extracts. 21 To confirm these findings in a mammalian transcription system, we utilized similar E-and D-box luciferase reporters in HEK293 cells ( Figure 1A) . Results show that alone neither Hand1, Hand1 A126FS (Hand1FS), or E12 transactivate ( Figure 1B) . When Hand1 is cotransfected with E12 (Hand1 þ E12) along with either an E-or D-box reporter significant transactivation (P < _ 0.05) is observed. Cotransfection of Hand1 A126FS and E12 (Hand1FS þ E12) results in a decrease of the Hand1-E12 heterodimer transcriptional activity consistent with previous analysis. 21 EMSA shows that E12 and (Hand1 þ E12) bind to the Ebox probe as homo-(red arrowhead) and heterodimers (black arrowhead), respectively ( Figure 1C) . Cotranslation of Hand1A126FS with E12 (Hand1 A126fs þ E12) results in undetectable shifting of the Ebox probe ( Figure 1C , asterisks). We engineered a Hand1
A126fs
-eGFP fusion construct and co-transfected this plasmid with an E12-DsRed fusion plasmid ( Figure 1D) .
Results show Hand1
A126fs -eGFP and E12-DsRed nuclear epifluorescence. These data support a model where Hand1 A126FS acts as a dominant negative factor.
Generation and analysis of a conditional Hand1 A126FS allele
To test if expression of Hand1 A126FS is causative of HLHS, we engineered a conditional-activation allele by introducing the identified p.Ala126Profs13X mutation into the murine Hand1 locus that includes a stop-flox (SF) cassette that bocks the transcription and translation of the mutant Hand1 protein (Figure 2A) . The mutation deletes the G in codon 126 (alanine) producing a 
3F and K) and elongated OFTs (white bars) indicating that morphological alignment of the forming heart is compromised. Abnormal haemorrhaging is apparent in Nkx2.5 Cre ; Hand1 A126FS/þ mutants ( Figure 3K ).
Section analysis of Nkx2.5
Cre ; Hand1 A126FS/þ mutants reveals a poorly formed IVS that is positioned to the right of the endocardial cushions (compare Figure 3C and D with H, I and M and N), a thin compact zone (black lines Figure 3E , J, and O), and hypotrabeculation. Given that Hand1 is expressed within the myocardium of the left ventricle and a region of the SHF-derived myocardial cuff, but not the majority of the IVS or endocardium 25, 29 these phenotypes are consistent with both cellautonomous and non-cell autonomous defects in cardiogenesis.
Increased cell death is observed in hearts of Hand1 A126FS embryos
To determine the cause of the Nkx2.5
Cre ; Hand1 A126FS/wt mutant heart phenotypes, we looked at cell death using Lysotracker staining at E10.5 
Altered gene expression is observed in hearts of Hand1 A126FS embryos
We next interrogated gene expression defining cardiogenesis. Wnt11 marks the precardiac mesoderm of the OFT and is essential for SHF development. 34 
Hand1
A126FS/þ mutant OFTs are elongated (Figure 5A and B; white bars).
The T-box transcription factor Tbx5 expression is largely restricted to the LV. 36 Compared with Hand1 SFA126FS controls, Nkx2.5
Cre ; Hand1
A126FS/þ mutant hearts reveal a broader domain of Tbx5 expression that includes the RV (Figure 5C and D; white arrowhead). Cardiac expression of Dkk3 generally marks the cardiac mesoderm becoming enriched within the IVS. 37, 38 Comparison of Dkk3 expression in Hand1 SFA126FS controls and Nkx2.5
Cre ;
A126FS/þ mutant hearts shows a largely comparable expression A126FS/þ mutants ( Figure 5 and F, white arrowhead). Cited1 is a trabecular maker and is reported to be downregulated in Hand1 cardiac conditional knockout mice. 12 Comparison of control and Nkx2.5
Cre ; Hand1 A126FS/þ mutant hearts reveals no difference in Cited1 expression ( Figure 5G and H) . LV size of Hand1 A126FS/þ mutants is indistinguishable from controls.
Next we performed section ISH at E10.5 and E12.5 on Hand1 SFA126FS controls and Nkx2.5
Cre ; Hand1 A126FS/þ mutants ( Figure 6) . We looked at the trabecular markers Bmp10, 39 Nppa (Anf), 40 and Cited1 ( Figure 6A-L) .
Results show that expression is largely unaltered. Analysis of Cxcl12 expression, a cardiomyocyte ligand required for coronary formation, 41, 42 shows Cxcl12 expression is markedly upregulated (Figure 6M -P; Figure 4 Nkx2.5
Cre/þ ; Hand1 A126FS/þ hearts display an increase in both cell autonomous and non-cell autonomous cell death. Control Hand1 SF-A126fs/þ (A, B) and Nkx2.5 Cre/þ ; Hand1 A126FS/þ mutants (C, D) were assayed for cell death using Lysotracker staining in wholemount at E10.5 and E11. 5 . Control hearts show little cell death. Increased cell death is observed in OFT, RV, and, LV of Nkx2.5
Cre/þ ; Hand1 A126FS/þ mutants (white arrows). (E-H) EdU wholemount proliferation analysis at E10.5 and E11. 5 . Results show no obvious differences in between control and mutant hearts. Data represent an example of each genotype. Six embryos per genotype were examined. ra, right atria; la, left atria; rv, right ventricle; lv, left ventricle. Scale bars 150 lm.
HAND1 frameshift mutation does not cause HLHS arrowheads). Similarly, Dkk3 expression ( Figure 6Q-T) shows a marked expansion of expression consistent with E11.5 analysis ( Figure 5) . Examination of the compact zone markers Tbx20 43,44 and Hey2 45, 46 show that Tbx20 expression is upregulated in Nkx2.5
Cre ; H and 1 A126FS/þ mutants ( Figure 6U -Xl, black arrowheads) while Hey2 expression is decreased ( Figure 6Y -Ab, asterisks).
As we observe a thin walled myocardium in the Nkx2.5
Cre ; Hand1 A126FS/þ mutants, we also looked at endocardial and epicardial gene expression which can influence myocardial growth [47] [48] [49] and production of cardiac myofibroblasts and coronary vasculature. [50] [51] [52] [53] Expression analysis of the endocardial markers Hand2, Flt1, Tie2, Nrg1, Nrp1, VegfR2, and NfactC1 and epicardial markers WT1 and Tcf21 by QPCR from E10.5 RNA control and mutant hearts revealed no observable changes in expression (see Supplementary material online, Figure S1 ). As some Nkx2.5
Cre ; Hand1 A126FS/þ mutants survive to E14.5, we looked at these mutant phenotypes ( Figure 7) . H&E sections of E14.5 Nkx2.5
Cre ; Hand1 A126FS/þ mutant hearts reveal obvious VSDs both membranous and muscular in nature ( Figure 7A and B) . Although the LV compact zone is thin when compared with controls (black bars), LV chamber size is clearly proportional to RV size and similar to controls. We observe lower levels of Bmp10 expression ( Figure 7C-F) , which may reflect either real changes in expression or a near death state of these mutants. Dkk3 maintains its enhanced expression when comparing Nkx2.5
Cre ; Hand1 A126FS/þ mutants to controls suggesting that death is not causative of decreased Bmp10 expression.
aMHC-cre and Mef2CAHF-cre activation of the Hand1 A126FS/þ allele results in improved phenotype and viability
One caveat is that the Nkx2.5
Cre knock-in allele could have influence on
Hand1 LV expression. 54 To help address the Nkx2.5 contribution, we employed the aMHC-Cre transgenic mice that recombines within E9.5 cardiomyocytes. 26 aMHC-Cre tg/þ ; Hand1 A126FS/þ embryos were obtained at expected ratios at E10.5 and E14.5 (see Supplementary material online, Table S2 ). To our surprise, we identified surviving aMHC-Cre tg/þ ; Hand1 A126FS/þ neonatal mice at a frequency of 0.11. We looked at cardiac morphology and expression of Nppa (Anf) at E14.5 (see Supplementary material online, Figure S2A and B). Results show indistinguishable differences in phenotype and in Anf expression between control and aMHC-Cre tg/þ ; Hand1 A126FS/þ mutants. We then examined P60 adult hearts for phenotype. Bifurcated aMHC-Cre tg/þ ; Hand1 A126FS/þ hearts appear slightly hypertrophied and lack a well define apex (see Supplementary material online, Figure S2D and E). Mutant adults do not exhibit HLHS. Next, we looked at Mef2CAHF-Cre; Hand1 A126FS/þ mutants. 27 activates Hand1 A126FS within the SHF-derived myocardial cuff. Mef2CAHF-Cre; Hand1 A126FS/þ mutants survive to birth at normal frequency (see Supplementary material online, Table S3 ) exhibiting a normal LV chamber; however, RV size appears reduced at E14.5 and at p60 (see Supplementary material online, Figure S2C and F). We assayed expression of Wnt11, Tbx5, Dkk3, and Cited1 by wholemount ISH in both aMHC-and Mef2CAHF-Cre E10.5 mutants (see Supplementary material online, Figure S3 ). aMHC-Cre mutants exhibit a more normal OFT (Wnt11 staining white bar) and expression of Tbx5 maintains its LV specific expression (see Supplementary material online, Figure S3A Figure S3C) . Expression of Tbx5, Dkk3, and Cited1 are unaffected, consistent with Mef2CAHF-Cre expression (see Supplementary material online, Figure S3F , I, L).
Mef2CAHF-Cre
Discussion
Left-sided cardiac defects have poor clinical outcomes. [1] [2] [3] In contrast to the increasing mechanistic understanding of congenital defects affecting Figure 5 Wholemount ISH of Nkx2.5
Cre/þ ; Hand1 A126FS/þ mutant embryos reveals altered cardiac gene expression during heart formation. E11.5 Nkx2.5 þ/þ ; Hand1 SF-A126FS/þ control (A, C, E, G) and HAND1 frameshift mutation does not cause HLHS the OFT, 35, [55] [56] [57] little is understood of the underlying mechanisms causative of HLHS. Hand1 expression and lineage is largely restricted to the LV. 10, 25 In light of several studies implicating HAND1 in the genesis of
Tetralogy of Fallot, 19 VSDs, 20 and HLHS 9,21 in humans along with published evidence demonstrating a high frequency of HAND1 somatic mutations observed from fixed tissues that are not encountered from fresh tissue 22 -the follow up on these controversial findings in an in vivo system was imperative. The p.Ala126Profs13X Hand1 mutation was identified in hypoplastic hearts from the Leipzig University fixed tissue collection 23 and reported to act as a dominant negative in yeast. 21 We confirm this result in mammalian expression analysis (Figure 1) . Given we observe a loss of DNA binding, we hypothesize that the mutant Hand1 protein dimerizes with both wild-type Hand1, Hand2, and E-proteins when they are coexpressed. Twist-family bHLH factors are wellestablished to be promiscuous in dimer partner choice and the disruption of phosphoregulation of evolutionarily conserved bHLH residues regulating dimerization is directly associated with human disease such as in Saethre Chotzen Syndrome. 14 Table S2 ) displaying normal looking hearts at E14.5 that become enlarged by P60 (see Supplementary material online, Figure S2 ). Given the later activation of Hand1 A126fs by aMHC-Cre, we cannot distinguish the difference in phenotypes as resulting from genetic interactions with Nkx2.5 or differences in temporal activation or both. Nevertheless, neither Cre driver results in HLHS when crossed to the HAND1 SFA126fs allele. Mef2CAHF-Cre generated mutants are born and exhibit elongated OFTs similar to Nkx2.5
Cre generated mutants (see Supplementary material online, Figure S3 ). Wholemount expression shows consistent Wnt11 elongation with no effect on LV gene expression. From this data, we conclude that p.Ala126Profs13X Hand1, even if somatically acquired, is not causative of HLHS. As we considered the high frequency reported in the Leipzig samples (0.77) 9, 21 for the HAND1 A126fs mutation juxtaposed to the finding that no HAND1 mutations were observed from interrogation of non-fixed HLHS patient samples, 22 it suggests to us that DNA modifications via tissue fixation is the source of this discrepancy. Given this, we are not confident that HAND1 A126fs mutation phenotypes are biologically relevant to human CHDs, although they do reveal some insight into Hand1 role in cardiogenesis. Data from HLHS patients induced pluripotent stem cells show reduced levels of Hand1 and Hand2 in differentiating cardiomyocytes, suggesting that although protein mutations may not be commonly encountered the alteration of transcriptional regulation maybe more frequent explaining the association between Hand1 and CDHs. 60 Indeed, changes in HAND1 DNA methylation status is reported in Tetralogy of Fallot patients. 61 Additionally, two HAND1 point mutations were reported (p.G73S and p.K152N) in a study from screens of peripheral blood. 62 Such simple point mutations are likely far less deleterious than a truncated protein.
The cardiac developmental abnormalities observed in Nkx2.5
Cre ; Hand1 A126FS/þ mouse embryos do present a unique phenotype 63 hearts were growth expanded and lacked an IVS. Collectively, these models suggest that cardiomyocyte growth/cell death is affected but the molecular mechanisms affected are still elusive; however, we can conclude that the expression of either wild-type 63 or a truncated Hand1 protein (this study) can be more deleterious than the conditional deletion of Hand1. 12 In considering the defects observed in Nkx2.5
Cre ; Hand1 A126FS/þ mice, VSDs are a common CHD encountered in human births whereas in mice these defects are often associated with embryonic lethality. VSDs have a wide spectrum of aetiologies and encountering them in mouse mutants is common. Cardiomyocyte cell death is also observed at an abnormal level ( Figure 4) . This phenotype is not normally encountered in models of CHDs but is common in adult heart disease. 64 A126FS/þ hearts. These phenotypes are accompanied by altered trabecular and compact zone gene expression where some genes are down regulated such as Hey2 ( Figure 6 ) and Bmp10 at E14.5 ( Figure 7) ; however, most gene expression changes identified show an increased or expanded expression (CxCl12, Dkk3, Tbx5, Tbx20; Figures 6 and 7) . This finding could suggest that Hand1 has repressive transcriptional functions although previous findings do not show such changes in loss-of-function analysis. [10] [11] [12] [13] Alternatively, expanded expression could result from feedback regulation. Tbx5 for example is restricted to the LV and ChIP-Seq analysis 67 suggests that Tbx5 may be a Hand1 regulator. Interestingly, Tbx5 expression is expanded within the RV where Hand1 is not expressed, suggesting a non-cell autonomous mechanism. Tbx5 expansion is only observed within Nkx2.5
Cre ; Hand1 A126FS/þ hearts and not when either the aMHC-Cre or Mef2CAHF-Cre is employed ( Figure 5 ; see Supplementary material online, Figure S3 ). The Nkx2.5 Cre haploinsufficiency combined with the earlier activation of Hand1 A126FS/þ expression than aMHC-Cre (E7.5 vs.
E9.5) could both influence this phenotype. Mef2CAHF-Cre recombines Hand1 at E7.5 but not within the LV, collectively limiting our ability to distinguish between a temporal and/or genetic mechanism. Together, these data suggest that although the idea of acquiring a somatic mutation in Hand1 as a mechanism to account for HLHS or any CHD is attractive, the likelihood of this occurring in HAND1 is low. We speculate that it is possible and perhaps likely that mutations within Hand1 enhancer sequences that alter its spatiotemporal expression would be an inheritable HAND1 mutation and identification of human small nucleotide polymorphisms in HAND1 further supports this idea. 68 
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